Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05253755 · ClinicalTrials.gov registry record · Phase 2
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
A Phase 2 study, sponsored by DermBiont.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05253755 is a Phase 2 study that was terminated before completion, run by DermBiont. The registered enrollment target is 10 participants.
The verdict
NCT05253755, a Phase 2 study, was terminated before completion, sponsored by DermBiont.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis
Interventions
- BIOLOGICAL DBI-001
- BIOLOGICAL Aqueous gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-09-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05253755
The ClinicalTrials.gov registry entry for NCT05253755 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DermBiont, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DBI-001 is the first listed.
NCT05253755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05253755 about?
NCT05253755 is a clinical study titled "Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel". The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis
What is the current status of trial NCT05253755?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2021-10-06. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT05253755?
The interventions under investigation include: DBI-001 (BIOLOGICAL), Aqueous gel (BIOLOGICAL).
Who is sponsoring clinical trial NCT05253755?
This trial is sponsored by DermBiont, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.